+34 985 20 74 34
effichronic@ficyt.es
EFFICHRONIC

Menu

Skip to content
  • Home
  • About
  • Partners
    • CSPA-SESPA-FICYT
    • CHUM
    • EMC
    • EOG
    • QISMET
    • UVEG-Polibienestar
  • Work Packages
  • Deliverables
  • Publications
  • News
  • Intranet
  • Newsletter

Newsletter

EFFICHRONIC > Newsletter

  • Newsletter 1, December 2017
  • Newsletter 2, June 2018
  • Newsletter  3, December 2018
  • Newsletter  4, June 2019
  • Newsletter  5, January 2020

Upcoming Events

Apr
2
Thu
all-day World Autism Awareness Day
World Autism Awareness Day
Apr 2 all-day
World Autism Awareness Day
World Autism Awareness Day (WAAD) aims to put a spotlight on the hurdles that people with autism – and others living with autism – face every day. I ∞ autismo #WorldAutismAwarenessDay #WAADRead More...
Apr
7
Tue
all-day World Health Day
World Health Day
Apr 7 all-day
World Health Day
The World Health Day is a global health awareness day celebrated every year on 7 April, under the sponsorship of the World Health Organization (WHO), as well as other related organizations.
View Calendar
Add
  • Add to Timely Calendar
  • Add to Google
  • Add to Outlook
  • Add to Apple Calendar
  • Add to other calendar
  • Export to XML

Follow us

EFFICHRONICFollow

This activity is part of the project EFFICHRONIC (GA 738127) which has received funding from the European Union’s Health Programme (2014- 2020)

EFFICHRONIC
effichronicEFFICHRONIC@effichronic·
26 Mar

In 2009, the New York-based @AKFUS and @epilepsy_ns joined forces to launch Purple Day internationally. The aim to support persons living with epilepsy, their communities and support ongoing research.
@EpilepsyADDL @PurpleDay
#PurpleDay #Epilepsia #epilepsyawareness

Reply on Twitter 1243070178952392704Retweet on Twitter 1243070178952392704Like on Twitter 12430701789523927041Twitter 1243070178952392704
effichronicEFFICHRONIC@effichronic·
25 Mar

How to prevent yourself #Coronavirus #COVIDー19 #WashYourHands #MantainSocialDistance #AvoidContact and the most important: #StayAtHomeSaveLives

Reply on Twitter 1242718108109934592Retweet on Twitter 12427181081099345921Like on Twitter 12427181081099345921Twitter 1242718108109934592
effichronicEFFICHRONIC@effichronic·
24 Mar

#coronavirus
#COVID19
#wecantogether

Reply on Twitter 1242440974275620864Retweet on Twitter 1242440974275620864Like on Twitter 12424409742756208641Twitter 1242440974275620864
effichronicEFFICHRONIC@effichronic·
23 Mar

From @Effichronic and @EffichronicAst1 we want to participate in @OMS challenge #SafeHands. #WastYourHands and #StopCoronavirus
#WorldWaterDay

Reply on Twitter 1242094164591947790Retweet on Twitter 1242094164591947790Like on Twitter 12420941645919477901Twitter 1242094164591947790
Retweet on TwitterEFFICHRONIC Retweeted
WHO_EuropeWHO/Europe@WHO_Europe·
23 Mar

The #coronavirus disease Solidarity Response Fund is raising money from a wide range of donors to support the work of the WHO and partners to help countries respond to #COVID19.

Find out more ➡️ https://bit.ly/3bhueHS

Reply on Twitter 1241989059163164673Retweet on Twitter 124198905916316467322Like on Twitter 124198905916316467327Twitter 1241989059163164673
Load More...

Project Information

This website is part of the project ‘EFFICHRONIC’ which has received funding from the European Union’s Health Programme (2014-2020). Ref: 738127.  Co-funded by the Health Programme of the European Union

Project Title

Enhancing health systems sustainability by providing cost-efficiency data based interventions for chronic management in stratified population based on clinical and socio-economic determinants of health.

More Info

  • Sitemap
  • Contact
  • Data Protection
  • Disclaimer

 

Copyright © EFFICHRONIC
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
  • Home
  • About
  • Partners
    • CSPA-SESPA-FICYT
    • CHUM
    • EMC
    • EOG
    • QISMET
    • UVEG-Polibienestar
  • Work Packages
  • Deliverables
  • Publications
  • News
  • Intranet
  • Newsletter
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok